La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Winner Medical Gestion

Gestion contrôle des critères 2/4

We currently do not have sufficient information about the CEO.

Informations clés

Jianquan Li

Directeur général

CN¥3.1m

Rémunération totale

Pourcentage du salaire du PDG	n/a
Durée du mandat du directeur général	3.1yrs
Propriété du PDG	n/a
Durée moyenne d'occupation des postes de direction	pas de données
Durée moyenne du mandat des membres du conseil d'administration	3.1yrs

Mises à jour récentes de la gestion

Recent updates

Estimating The Fair Value Of Winner Medical Co., Ltd. (SZSE:300888)

Aug 19

Investors Could Be Concerned With Winner Medical's (SZSE:300888) Returns On Capital

Aug 02

Is Winner Medical (SZSE:300888) Using Too Much Debt?

Jul 15

Winner Medical (SZSE:300888) Will Pay A Smaller Dividend Than Last Year

May 31

There May Be Reason For Hope In Winner Medical's (SZSE:300888) Disappointing Earnings

May 01

There Are Reasons To Feel Uneasy About Winner Medical's (SZSE:300888) Returns On Capital

Apr 26

PDG

Jianquan Li (67 yo)

3.1yrs

Titularisation

CN¥3,073,400

Compensation

Mr. Jianquan Li is Chief Executive Officer of Winner Medical Co., Ltd. and serves as its Non-Independent Director since July 13, 2021. He also serves as Chairman of Winner Medical Co., Ltd.

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Jianquan Li	CEO & Chairman	3.1yrs	CN¥3.07m	pas de données
Xiuyuan Fang	Non-Independent Director	3.1yrs	CN¥1.64m	0.020% CN¥ 2.9m
Xiaodan Xu	Non-Independent Director	3.1yrs	CN¥1.06m	0.0039% CN¥ 574.3k
Ke Liu Key	Independent Director	3.1yrs	CN¥180.00k	pas de données
Zhenwei Guo	Non-Independent Director	3.1yrs	pas de données	pas de données
Jianfeng Peng	Independent Director	3.1yrs	CN¥180.00k	pas de données
Jiawei Xie	Independent Director	3.1yrs	CN¥180.00k	pas de données
Tingting Zhang	Chairman of the Board of Supervisors	3.1yrs	pas de données	pas de données
Hua Liu	Employee Representative Supervisor	no data	pas de données	0.0038% CN¥ 555.2k
Yan Zhang	Supervisor	1.1yrs	pas de données	0.00086% CN¥ 126.7k

3.1yrs

Durée moyenne de l'emploi

51yo

Âge moyen

Conseil d'administration expérimenté: 300888's board of directors are considered experienced (3.1 years average tenure).

Winner Medical Gestion

Gestion contrôle des critères 2/4

Informations clés

Mises à jour récentes de la gestion

Winner Medical Co., Ltd., Annual General Meeting, May 21, 2024

High number of new and inexperienced directors

High number of new and inexperienced directors

Winner Medical Co., Ltd., Annual General Meeting, May 13, 2022

Recent updates

Estimating The Fair Value Of Winner Medical Co., Ltd. (SZSE:300888)

Investors Could Be Concerned With Winner Medical's (SZSE:300888) Returns On Capital

Is Winner Medical (SZSE:300888) Using Too Much Debt?

Winner Medical Co., Ltd. to Report First Half, 2024 Results on Aug 20, 2024

Winner Medical (SZSE:300888) Will Pay A Smaller Dividend Than Last Year

Dividend of CN¥0.50 announced

Winner Medical Co., Ltd. Announces Final Cash Dividend on A Shares for 2023, Payable on 04 June 2024

Price target decreased by 11% to CN¥37.77

Consensus EPS estimates fall by 20%

There May Be Reason For Hope In Winner Medical's (SZSE:300888) Disappointing Earnings

Winner Medical Co., Ltd. Proposes Final Cash Dividend for the Year 2023

There Are Reasons To Feel Uneasy About Winner Medical's (SZSE:300888) Returns On Capital

First quarter 2024 earnings released: EPS: CN¥0.31 (vs CN¥0.64 in 1Q 2023)

Winner Medical Co., Ltd., Annual General Meeting, May 21, 2024

Estimating The Fair Value Of Winner Medical Co., Ltd. (SZSE:300888)

Winner Medical Co., Ltd. to Report Q1, 2024 Results on Apr 25, 2024

Does Winner Medical (SZSE:300888) Have A Healthy Balance Sheet?

Now 21% overvalued

There's No Escaping Winner Medical Co., Ltd.'s (SZSE:300888) Muted Earnings

Investor sentiment improves as stock rises 24%

Now 26% overvalued

Winner Medical Co., Ltd. (SZSE:300888) announces an Equity Buyback for CNY 200 million worth of its shares.

Winner Medical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024

Price target decreased by 9.2% to CN¥50.82

Third quarter 2023 earnings released: EPS: CN¥2.49 (vs CN¥0.61 in 3Q 2022)

New major risk - Revenue and earnings growth

Winner Medical Co., Ltd. to Report Q3, 2023 Results on Oct 24, 2023

Consensus EPS estimates increase by 34%, revenue downgraded

Second quarter 2023 earnings released: EPS: CN¥0.52 (vs CN¥0.92 in 2Q 2022)

Winner Medical Co., Ltd. to Report First Half, 2023 Results on Aug 16, 2023

Consensus EPS estimates increase by 38%, revenue downgraded

Winner Medical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 02 June 2023

Winner Medical Co., Ltd. Approves Cash Dividend for the Year 2022

Price target decreased by 9.3% to CN¥84.33

First quarter 2023 earnings released: EPS: CN¥0.89 (vs CN¥0.84 in 1Q 2022)

Now 20% undervalued after recent price drop

Now 20% undervalued

Price target increased to CN¥88.97

High number of new and inexperienced directors

Now 23% undervalued after recent price drop

Third quarter 2022 earnings released: EPS: CN¥0.85 (vs CN¥0.81 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥1.28 (vs CN¥0.66 in 2Q 2021)

Price target increased to CN¥84.00

Winner Medical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on May 27, 2022

Winner Medical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on May 27, 2022

Winner Medical Co., Ltd. Announces Dividend for 2021

Price target decreased to CN¥84.58

Consensus revenue estimates fall by 11%

First quarter 2022 earnings: EPS and revenues miss analyst expectations

High number of new and inexperienced directors

Winner Medical Co., Ltd., Annual General Meeting, May 13, 2022

Winner Medical Co., Ltd. Announces Final Dividend Proposal for 2021

Winner Medical Co., Ltd. (SZSE:300888) agreed to acquire 55% stake in Zhejiang Longtai Medical Technology Co., Ltd. from Wu Kangping, Huang Lepei and Wu Di for CNY 727.54 million.

Price target decreased to CN¥97.71

Winner Medical Receives U.S. FDA Market Access for the Silver Alginate Dressing

Investor sentiment deteriorated over the past week

Price target decreased to CN¥110

Third quarter 2021 earnings released: EPS CN¥0.81 (vs CN¥5.63 in 3Q 2020)

Winner Medical Co., Ltd. (SZSE:300888) announces an Equity Buyback for CNY 500 million worth of its shares.

Second quarter 2021 earnings released: EPS CN¥0.66 (vs CN¥1.90 in 2Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Winner Medical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2020, Payable on May 20, 2021

Full year 2020 earnings released: EPS CN¥9.80 (vs CN¥1.45 in FY 2019)

Winner Medical Co., Ltd. to Report Fiscal Year 2020 Results on Apr 20, 2021

New 90-day low: CN¥142

Investor sentiment deteriorated over the past week

New 90-day high: CN¥204

New 90-day high: CN¥189

New 90-day high: CN¥179

Winner Medical Co., Ltd. has completed an IPO in the amount of CNY 3.715 billion.